» Articles » PMID: 2207310

Induction of Mixed Erythroid-megakaryocyte Colonies and Bipotential Blast Cell Colonies by Recombinant Human Erythropoietin in Serum-free Culture

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 1990 Oct 1
PMID 2207310
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The effects of recombinant human erythropoietin (rEp) on murine hematopoietic progenitors were studied using a serum-free culture. A high concentration of rEp stimulated the formation of mixed erythroid-megakaryocyte colonies (EM colonies) and blast cell colonies, as well as erythroid colonies, erythroid bursts, and megakaryocyte colonies from normal mouse bone marrow cells. Direct effects of rEp on EM colony, megakaryocyte colony, and erythroid burst formation were confirmed by depletion of accessory cells such as T cells, B cells, and macrophages from crude bone marrow cells, and inhibition of the colonies by the addition of rabbit anti-rEp antibody to the culture in a dose-dependent fashion. Replating experiments were performed to confirm the differentiating ability of blast cell colonies grown in the presence of rEp. Most of the blast cell colonies yielded not only secondary erythroid colonies but also megakaryocyte colonies in the presence of 2 IU/mL rEp. Some of the blast cell colonies produced secondary EM colonies in the presence of 16 IU/ml rEp of 2 IU/mL rEp plus interleukin-3, although no granulocyte-macrophage colonies were found in the secondary culture. These results suggest that Ep acts not only as a late-acting factor that is specific for erythroid progenitors, but also as a bipotential EM-stimulating factor for murine hematopoietic cells.

Citing Articles

The effect of thrombopoietin on erythroid progenitors in Diamond-Blackfan anemia.

Kawasaki H, Nakano T, Kohdera U, Kobayashi Y Int J Hematol. 2002; 75(4):382-4.

PMID: 12041668 DOI: 10.1007/BF02982128.


Erythroid progenitors differentiate and mature in response to endogenous erythropoietin.

Sato T, Maekawa T, Watanabe S, Tsuji K, Nakahata T J Clin Invest. 2000; 106(2):263-70.

PMID: 10903342 PMC: 314307. DOI: 10.1172/JCI9361.


Alternative testing systems for evaluating noncarcinogenic, hematologic toxicity.

Parchment R Environ Health Perspect. 1998; 106 Suppl 2:541-57.

PMID: 9599702 PMC: 1533375. DOI: 10.1289/ehp.98106541.


Erythropoietin-independent erythrocyte production: signals through gp130 and c-kit dramatically promote erythropoiesis from human CD34+ cells.

Sui X, Tsuji K, Tajima S, Tanaka R, Muraoka K, Ebihara Y J Exp Med. 1996; 183(3):837-45.

PMID: 8642288 PMC: 2192354. DOI: 10.1084/jem.183.3.837.


Suppression of erythro-megakaryocytopoiesis and the induction of reversible thrombocytopenia in mice transgenic for the thymidine kinase gene targeted by the platelet glycoprotein alpha IIb promoter.

Tronik-Le Roux D, Roullot V, Schweitzer A, Berthier R, Marguerie G J Exp Med. 1995; 181(6):2141-51.

PMID: 7760003 PMC: 2192050. DOI: 10.1084/jem.181.6.2141.